Work

Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): A subgroup analysis from the phase 3 A.R.R.O.W. study.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.8027

Authors: Maria-Victoria Mateos, Heinz Ludwig, Shaji Kumar, Cara Ann Rosenbaum, Mei Huang, Amanda Goldrick, Julie Blaedel, Meletios A. Dimopoulos

Institutions: Instituto de Investigación Biomédica de Salamanca, Wilhelminen Hospital, Mayo Clinic, Weill Cornell Medicine, Amgen (United States), National and Kapodistrian University of Athens

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955567726

Cites:

Cited by: 2

Related to: 10